Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Public ClinicalTrials.gov record NCT00702819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1 Trial of Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Study identification
- NCT ID
- NCT00702819
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Vision Research Foundation
- Other
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Weeks to 36 Weeks
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- May 31, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Jan 26, 2010
2008 – 2009
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital | Los Angeles | California | 90027 | — |
| Jules Stein Eye Center | Los Angeles | California | 90095 | — |
| California Vitreoretinal Center | Menlo Park | California | 94025 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Emory Eye Center | Atlanta | Georgia | 30322 | — |
| Children's Hospital / Dept. Ophthalmology | Boston | Massachusetts | 02115 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| University of North Carolina/Ophthalmology | Chapel Hill | North Carolina | 27599-7040 | — |
| University of Pennsylvania/Scheie Eye Institute | Philadelphia | Pennsylvania | 19104 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00702819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2010 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00702819 live on ClinicalTrials.gov.